CTAG2
|
Cancer/testis antigen 2
|
NM_020994.3
|
11.6
|
IL13RA2
|
Interleukin 13 Receptor, alpha 2
|
NM_000640.2
|
10.7
|
IFI27
|
Interferon, alpha-inducible protein 27
|
NM_005532.3
|
8.3
|
TPM2
|
Tropomyosin 2 (beta)
|
NM_213674.1
|
7.8
|
RPL14
|
Ribosomal protein L14
|
NM_001034996.1
|
6.6
|
CCNA1
|
Cyclin A1
|
NM_003914.3
|
6.6
|
RGS5
|
G-protein signaling 5 regulator
|
NM_003617.3
|
6.0
|
FBN2
|
Fibrillin 2
|
NM_001999.3
|
5.9
|
D4S234E
|
DNA segment on chromosome 4 (unique)
|
NM_001040101.1
|
5.5
|
BST2
|
Bone marrow stromal cell antigen 2
|
NM_004335.2
|
5.1
|
QPCT
|
Glutaminyl-peptide cyclotransferase
|
NM_012413.3
|
4.8
|
TNFSF4
|
Tumor necrosis factor (ligand) superfamily, member 4
|
NM_003326.3
|
4.6
|
RGS5
|
Regulator of G-protein signaling 5
|
NM_003617.3
|
4.6
|
SPOCK1
|
Sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1
|
NM_004598.3
|
4.6
|
SNHG8
|
Small nucleolar RNA host gene 8 (non-protein coding)
|
NR_003584.3
|
4.6
|
ANTXR1
|
Anthrax toxin receptor 1
|
NM_032208.2
|
4.5
|
CHST1
|
Carbohydrate sulfotransferase 1
|
NM_003654.5
|
4.5
|
MPZL2
|
Myelin protein zero-like 2
|
NM_005797.3
|
4.4
|
HEY2
|
Hairy/enhancer-of-spilt related with YRPW motif 2
|
NM_012259.2
|
4.3
|
SLITRK4
|
SLIT and NTRK-like family, member 4
|
NM_173078.3
|
4.2
|
SHISA2
|
Shisa homolog 2
|
NM_001007538.1
|
4.0
|
LRRC17
|
Leucine rich repeat containing 17, TV2
|
NM_005824.2
|
3.9
|
NUDT11
|
Nudix-type motif 11
|
NM_018159.3
|
3.8
|
RNASE1
|
Ribonuclease, Rnase A family, 1, TV1
|
NM_198235.2
|
3.7
|
SERPINE2
|
Serpin peptidase inhibitor, clade E, member 2
|
NM_006216.3
|
3.6
|
LIPG
|
Lipase, endothelial
|
NM_006033.2
|
3.4
|
PCSK5
|
Proprotein convertase subtilisin/kexin type 5
|
NM_006200.3
|
3.4
|
LPXN
|
Leupaxin
|
NM_004811.2
|
3.3
|
CXCR4
|
Chmeokine (C-X-C motif) receptor 4, TV2
|
NM_003467.2
|
3.2
|
TMEM200A
|
Transmembrane protein 200A
|
NM_052913.2
|
3.1
|
CXCR4
|
Chemokine (C-X-C motif) receptor 4, TV1
|
NM_001008540.1
|
3.1
|
RAB34
|
RAB34, member RAS onogene family
|
NM_031934.5
|
3.0
|
DPYSL3
|
Dihydropyrimidinase-like 3
|
NM_001387.2
|
2.9
|
FBXL13
|
F-box and leucine-rich repeat protein 13
|
NM_145032.3
|
2.9
|
PNMA2
|
Paraneoplastic Ma antigen 2
|
NM_007257.5
|
2.9
|
LOC440354
|
LOC440354
|
NR_002473.2
|
2.9
|
NLGN1
|
Neuroligin 1
|
NM_014932.2
|
2.8
|
DDIT4
|
DNA-damage-inducible transcript 4
|
NM_019058.2
|
2.8
|
PFN2
|
Profilin 2
|
NM_053024.3
|
2.8
|
GABBR2
|
Gamma-aminobutyric acid B receptor, 2
|
NM_005458.7
|
2.8
|
MEIS2
|
Meis homeobox 2
|
NM_172315.2
|
2.7
|
PMEPA1
|
Prostate transmembrane protein, androgen induced 1
|
NM_199169.2
|
2.7
|
LOC647307
|
LOC647308
|
XR_039752.1
|
2.7
|
PLEK2
|
Pleckstrin 2
|
NM_016445.1
|
2.7
|
CARD11
|
Caspase recruitment domain family, member 11
|
NM_032415.4
|
2.6
|
SNORD13
|
Small nucleolar RNA, C/D box 13, small nucleolar RNA
|
NR_003041.1
|
2.6
|
GFPT2
|
Glutamine-fructoce-6-phosphate transaminase 2
|
NM_005110.2
|
2.6
|
FAP
|
Fibroblast activation protein, alpha
|
NM_004460.2
|
2.6
|
OCIAD2
|
OCIA domain containing 2, TV2
|
NM_152398.2
|
2.5
|
F2RL1
|
Coagulation factor II receptor-like 1
|
NM_005242.4
|
2.5
|
DSTYK
|
Dual serine/threonine and tyrosine protein kinase
|
NM_199462.2
|
2.5
|
LOC649497
|
LOC649498
|
XM_938576.1
|
2.5
|
LOC654194
|
LOC654195
|
XM_942669.1
|
2.5
|
NYNRIN
|
NYN domain and retroviral integrase containing
|
NM_025081.2
|
2.5
|
LOC387763
|
LOC387764
|
XM_941665.2
|
2.5
|
COL8A1
|
Collagen, type VIII, alpha 1
|
NM_020351.3
|
2.5
|
MGC39900
|
MGC39901
|
XM_936687.1
|
2.4
|
LTBP2
|
Latent transforming growth factor beta binding protein 2
|
NM_000428.2
|
2.4
|
RNASE1
|
Ribonuclease, Rnase A family, 1, TV3
|
NM_198232.2
|
2.4
|
IFI27L2
|
Interferon, alpha-inducible protein 27-like 2
|
NM_032036.2
|
2.4
|
SOX4
|
SRY (sex determining region Y)-box4
|
NM_003107.2
|
2.4
|
LRRC17
|
Leucine rich repeat containing 17, TV1
|
NM_001031692.2
|
2.3
|
DSE
|
Dermatan sulfate epimerase
|
NM_013352.2
|
2.3
|
CD44
|
CD44 molecule (Indian blood group), TV5
|
NM_001001392.1
|
2.3
|
LOC100131139
|
LOC100131140
|
XR_037336.1
|
2.3
|
CBS
|
Systathionine-beta-synthase
|
NM_000071.2
|
2.3
|
NT5DC2
|
5'-nucleotidase domain containing 2
|
NM_022908.2
|
2.3
|
NPFFR2
|
Neuropeptide FF receptor 2
|
NM_004885.2
|
2.3
|
LOC100129685
|
LOC100129686
|
XM_001723814.1
|
2.3
|
LXN
|
Latexin
|
NM_020169.3
|
2.3
|
MEX3B
|
Mex-3 homolog B
|
NM_032246.3
|
2.3
|
C1orf54
|
Chromosome 1 open reading frame 54
|
NM_024579.3
|
2.3
|
HDDC2
|
HD domain containing 2
|
NM_016063.2
|
2.3
|
LOC648823
|
LOC648824
|
XM_943477.1
|
2.3
|
CYB5A
|
Cytochrome b5 type A
|
NM_001914.3
|
2.3
|
PIR
|
Pirin (iron binding nuclear protein)
|
NM_001018109.2
|
2.3
|
GPR37
|
G protein-coupled receptor 37
|
NM_005302.2
|
2.3
|
PPAPDC1A
|
Phosphatidic acid phosphatase type 2 domain containing 1A
|
NM_001030059.1
|
2.3
|
CD44
|
CD44 molecule (Indian blood group), TV4
|
NM_001001391.1
|
2.2
|
LOC100131905
|
LOC100131906
|
XR_039334.1
|
2.2
|
CTAG1A
|
Cancer/testis antigen 1A
|
NM_139250.1
|
2.2
|
C4orf18
|
Chromosome 4 open reading frame 18
|
NM_016613.6
|
2.2
|
LDOC1
|
Leucine zipper, down-regulated in cancer 1
|
NM_012317.2
|
2.2
|
TGFBI
|
Transforming growth factor, beta-induced
|
NM_000358.2
|
2.2
|
COL5A2
|
Collagen, type V, alpha 2
|
NM_000393.3
|
2.2
|
NOX4
|
NADPH oxidase 4
|
NM_016931.3
|
2.2
|
TSHZ3
|
Teashirt zinc finger homeobox 3
|
NM_020856.2
|
2.2
|
FNDC3B
|
Fibronectin type III domain containing 3B, TV2
|
NM_001135095.1
|
2.2
|
KIT
|
V-kit
|
NM_001093772.1
|
2.2
|
ADAM19
|
ADAM metallopeptidase domain 19
|
NM_033274.3
|
2.2
|
JAM3
|
Junctional adhesion molecule 3
|
NM_032801.4
|
2.1
|
CGNL1
|
Cingulin-like 1
|
NM_032866.4
|
2.1
|
COL4A6
|
Collagen, type IV, alpha 6
|
NM_001847.2
|
2.1
|
BMX
|
BMX non-receptor tyrosine kinase
|
NM_001721.6
|
2.1
|
DUSP23
|
Dual specificity phosphatase 23
|
NM_017823.3
|
2.1
|
MMP2
|
Matrix metallopeptidase 2
|
NM_004530.4
|
2.1
|
NCAPD2
|
Non-SMC condensin I complex, subunit D2
|
NM_014865.3
|
2.1
|
CYBRD1
|
Cytochrome b reductase 1, TV1
|
NM_024843.2
|
2.1
|
FAM89A
|
Family with sequence similarity 89, member A
|
NM_198552.2
|
2.1
|
GAS6
|
Growth arrest-specific 6
|
NM_000820.2
|
2.1
|
S100A13
|
S100 calcium binding protein A13
|
NM_001024211.1
|
2.1
|
SMARCE1
|
SWI/SNF related, subfamily e, member 1
|
NM_003079.4
|
2.1
|
LOC643977
|
LOC643978
|
XM_932991.1
|
2.1
|
LFNG
|
O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
|
NM_001040167.1
|
2.1
|
MTMR11
|
Myotubularin related protein 11
|
NM_181873.3
|
2.1
|
ITGA10
|
Integrin, alpha 10
|
NM_003637.3
|
2.1
|
PTGFRN
|
Prostaglandin F2 receptor negative regulator
|
NM_020440.2
|
2.0
|
LOC644936
|
Actin, beta pseudogene
|
NR_004845.1
|
2.0
|
CPS1
|
Carbamoyl-phosphate synthase 1, mitochonfrial
|
NM_001875.4
|
2.0
|
C18orf56
|
Chromosome 18 open reading frame 56
|
NM_001012716.2
|
2.0
|
ADA
|
Adenosine deaminase
|
NM_000022.2
|
2.0
|
NETO2
|
Neuropilin and tolliod-like2
|
NM_018092.4
|
2.0
|
DKFZp761P0423
|
DKFZp761P0424
|
XM_291277.4
|
2.0
|
STC2
|
Stanniocalcin 2
|
NM_003714.2
|
2.0
|
PRKAR1A
|
Protein kinase, cAMP-dependent, regulatory, type I, alpha
|
NM_002734.3
|
2.0
|
EGFLAM
|
EGF-like, fibronectin type III and laminin G domains
|
NM_182801.2
|
2.0
|
SPECC1
|
Sperm antigen with calponin homology, coiled-coil domains 1
|
NM_001033555.2
|
2.0
|
FNDC3B
|
Fibronectin type III domain containing 3B, TV1
|
NM_022763.3
|
2.0
|
THOC3
|
THO complex 3
|
NM_032361.2
|
2.0
|
COL5A1
|
Collagen, type V, alpha 1
|
NM_000093.3
|
2.0
|
LANCL1
|
LanC lantibiotic synthetase component C-like 1
|
NM_006055.2
|
2.0
|
OCIAD2
|
OCIA domain containing 2, TV1
|
NM_001014446.1
|
2.0
|
LRIG1
|
Leucine-rich repeats and immunoglobulin-like domains 1
|
NM_015541.2
|
2.0
|
HOXB2
|
Homeobox B2
|
NM_002145.3
|
2.0
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
NM_003254.2
|
−2.0
|
NAAA
|
N-acylethanolamine acid amidase
|
NM_014435.3
|
−2.0
|
MAOA
|
Monoamine oxidase A
|
NM_000240.2
|
−2.0
|
MYOF
|
Myoferlin
|
NM_013451.3
|
−2.0
|
KISS1
|
KiSS metastasis-suppressor
|
NM_002256.3
|
−2.0
|
SLC25A22
|
Solute carrier family 25, member 22
|
NM_024698.5
|
−2.0
|
NOSIP
|
Nitric oxide synthase interacting protein
|
NM_015953.3
|
−2.0
|
COL1A2
|
Collagen, type I, alpha 2
|
NM_000089.3
|
−2.0
|
ZDHHC14
|
Zinc finger, DHHC-type containing 14
|
NM_024630.2
|
−2.0
|
HPCAL1
|
Hippocalcin-like 1
|
NM_134421.1
|
−2.0
|
VLDLR
|
Very low density lipoprotein receptor
|
NM_001018056.1
|
−2.0
|
LOC730525
|
LOC730525
|
XM_001126202.1
|
−2.0
|
BMP2
|
Bone morphogenetic protein 2
|
NM_001200.2
|
−2.0
|
ABLIM1
|
Actin binding LIM protein 1
|
NM_006720.3
|
−2.0
|
PIK3C2A
|
Phosphoinositide-3-kinase, class 2, alpha polypeptide
|
NM_002645.2
|
−2.0
|
IRF1
|
Interferon regulatory factor 1
|
NM_002198.2
|
−2.0
|
MBP
|
Myelin basic protein
|
NM_001025100.1
|
−2.0
|
PRKAR1B
|
Protein kinase, cAMP-dependent, regulatory type I, beta
|
NM_002735.2
|
−2.1
|
FAM101B
|
Family with sequence similarity 101, member B
|
NM_182705.2
|
−2.1
|
ERCC2
|
DNA excision repair protein 2
|
NM_000400.3
|
−2.1
|
CCND2
|
Cyclin D2
|
NM_001759.3
|
−2.1
|
HLA-B
|
Major histocompatibility complex, class I, B
|
NM_005514.6
|
−2.1
|
SYBU
|
Syntabulin
|
NM_001099743.1
|
−2.1
|
PDE2A
|
Phosphodiesterase 2A, cGMP-stimulated
|
NM_002599.4
|
−2.1
|
AKAP12
|
A kinase anchor protein 12
|
NM_005100.3
|
−2.1
|
CLEC2B
|
C-type lectin domain family 2, member B
|
NM_005127.2
|
−2.1
|
S100A4
|
S100 calcuim binding protein A4
|
NM_019554.2
|
−2.1
|
FST
|
Follistain
|
NM_013409.2
|
−2.2
|
SLC30A3
|
Solute carrier family 30, member 3
|
NM_003459.4
|
−2.2
|
PLIN2
|
Perilipin 2
|
NM_001122.3
|
−2.2
|
IL32
|
Interleukin 32
|
NM_001012633.1
|
−2.2
|
LOC100128252
|
LOC100128253
|
XM_001725603.1
|
−2.2
|
TIMM22
|
Translocase of inner mitochondrial membrane 22 homolog
|
NM_013337.2
|
−2.2
|
SYNM
|
Synemin, intermediate filament protein
|
NM_015286.5
|
−2.2
|
LOC729985
|
LOC729986
|
XM_001131964.1
|
−2.2
|
ADRB2
|
Adrenergic, beta-2-, receptor surface
|
NM_000024.5
|
−2.2
|
KIAA1274
|
KIAA1274
|
NM_014431.2
|
−2.2
|
PRR5
|
Proline rich 5
|
NM_001017529.2
|
−2.2
|
LOC387841
|
LOC387842
|
XM_932678.1
|
−2.3
|
CFI
|
Complement factor I
|
NM_000204.3
|
−2.3
|
LOC646836
|
LOC646837
|
XM_001718162.1
|
−2.3
|
COL1A1
|
Collagen, type I, alpha 1
|
NM_000088.3
|
−2.3
|
CCL2
|
Chemokine (C-C motif) ligand 2
|
NM_002982.3
|
−2.3
|
COL6A1
|
Collagen, type VI, alpha 1
|
NM_001848.2
|
−2.3
|
LOC201651
|
LOC201652
|
XR_017321.2
|
−2.3
|
GALNTL4
|
GalNAc-T-like protein 4
|
NM_198516.2
|
−2.3
|
S100A3
|
S100 calcuim binding protein A3
|
NM_002960.1
|
−2.4
|
ALDH1A1
|
Aldehyde dehydrogenase 1 family, member A1
|
NM_000689.4
|
−2.4
|
TNFRSF14
|
Tumor necosis factor receptor superfamily, member 14
|
NM_003820.2
|
−2.4
|
CAV1
|
Caveolin 1
|
NM_001753.4
|
−2.4
|
LAMC2
|
Laminin, gamma 2
|
NM_005562.2
|
−2.4
|
NOSTRIN
|
Nitric oxide synthase trafficker
|
NM_052946.3
|
−2.4
|
CEACAM1
|
Carcinoembryonic antigen-related cell adhesion molecule 1
|
NM_001024912.2
|
−2.4
|
CYYR1
|
Cysteine/tyrosine-rich 1
|
NM_052954.2
|
−2.5
|
SLC22A23
|
Solute carrier family 22, member 23
|
NM_021945.5
|
−2.5
|
ACSL5
|
Acyl-CoA synthetase long-chain family member 5
|
NM_016234.3
|
−2.5
|
AADAC
|
Arylacetamide deacetylase
|
NM_001086.2
|
−2.6
|
COLEC12
|
Collectin sub-family member 12
|
NM_130386.2
|
−2.6
|
KIAA1324L
|
KIAA1324-like
|
NM_152748.3
|
−2.6
|
RNASET2
|
Ribonuclease T2
|
NM_003730.4
|
−2.6
|
NXN
|
Nucleoredoxin
|
NM_022463.4
|
−2.6
|
PLA2G4C
|
Phospholipase A2, group IVC
|
NM_003706.2
|
−2.6
|
SERPINB2
|
Serpin peptidase inhibitor, clade B, member 2
|
NM_002575.2
|
−2.6
|
CETP
|
Cholesteryl ester transfer protein, plasma
|
NM_000078.2
|
−2.7
|
PLA2G16
|
Phospholipase A2, group XVI
|
NM_007069.3
|
−2.7
|
TNFSF18
|
Tumor necrosis factor superfamily, member 18
|
NM_005092.3
|
−2.8
|
CITED2
|
Cbp/p300-interacting transactivator 2
|
NM_006079.3
|
−2.8
|
C10orf116
|
Chromosome 10 open reading fame 116
|
NM_006829.2
|
−2.8
|
PROX1
|
Prospero homeobox 1
|
NM_002763.3
|
−2.9
|
PALM
|
Paralemmin
|
NM_002579.2
|
−2.9
|
ZSCAN18
|
Zinc finger and SCAN domain containing 18
|
NM_023926.4
|
−2.9
|
LEPREL1
|
Leprecan-like 1
|
NM_018192.3
|
−2.9
|
CTSH
|
Cathepsin H
|
NM_004390.3
|
−2.9
|
KHDRBS3
|
RNA-binding protein T-Star
|
NM_006558.1
|
−3.0
|
CDH11
|
Cadherin 11, type 2, OB-cadherin
|
NM_001797.2
|
−3.1
|
DDIT4L
|
DNA-damage-inducible transcript 4-like
|
NM_145244.3
|
−3.2
|
GAPDHL6
|
GAPDHL7
|
XM_001726954.1
|
−3.2
|
NR5A2
|
Nuclear receptor subfamily 5, group A, member 2
|
NM_003822.3
|
−3.3
|
ABCA3
|
ATP-binding cassette, sub-family A, member 3
|
NM_001089.2
|
−3.3
|
MARCH2
|
Membrane-associated ring finger 2
|
NM_001005416.1
|
−3.3
|
CDKN2A
|
Cyclin-dependent kinase inhibitor 2A
|
NM_000077.4
|
−3.3
|
MGP
|
Matrix Gla protein
|
NM_000900.3
|
−3.3
|
ALDH1A2
|
Aldehyde dehydrogenase 1 family, member A2
|
NM_170697.2
|
−3.5
|
HOXB7
|
Homeobox B7
|
NM_004502.3
|
−3.5
|
EMCN
|
Endomucin
|
NM_016242.3
|
−3.5
|
ANGPT2
|
Angiopoietin 2
|
NM_001147.2
|
−3.5
|
GIMAP5
|
GTPase, IMAP family member 5
|
NM_018384.4
|
−3.6
|
NDN
|
Necdin homolog
|
NM_002487.2
|
−3.8
|
TACSTD2
|
Tumor associate calcuim signal transducer 2
|
NM_002353.2
|
−3.8
|
KRT19
|
Keratin 19
|
NM_002276.4
|
−3.8
|
FAM174B
|
Family with sequence similarity 174, member B
|
NM_207446.2
|
−3.9
|
CECR1
|
Cat eye syndrome chromosome region, candidate 1
|
NM_177405.1
|
−4.2
|
GPR116
|
G protein-coupled receptor 116
|
NM_015234.4
|
−4.3
|
TNFRSF6B
|
Tumor necrosis factor superfamily, member 6b, decoy
|
NM_032945.2
|
−4.3
|
PIEZO2
|
Piezo-type mechanosensitive ion channel component 2
|
NM_022068.2
|
−4.4
|
UCHL1
|
Ubiquitin carboxyl-terminal esterase L1
|
NM_004181.4
|
−4.9
|
KBTBD11
|
Kelch repeat and BTB domain containing 11
|
NM_014867.2
|
−5.3
|
LOC375295
|
LOC375296
|
XM_374020.4
|
−5.5
|
HSD17B2
|
Hydroxysteroid dehydrogenase 2
|
NM_002153.2
|
−8.4
|
LYVE1
|
Lymphatic vessel endothelial hyaluronan receptor 1
|
NM_006691.3
|
−8.8
|
PDPN
|
Podoplanin
|
NM_001006625.1
|
−15.8
|
GYPC
|
Glycophorin C
|
NM_016815.3
|
−22.6
|
MMP1
|
Matrix metallopeptidase 1
|
NM_002421.3
|
−25.8
|
FABP4
|
Fatty acid binding protein 4, adipocyte
|
NM_001442.2
|
−28.1
|
CLDN11 |
Claudin 11 |
NM_005602.5 |
−36.9 |